$Iterum Therapeutics (ITRM.US)$$Iterum Therapeutics (ITRM.US)$5.5x mil of share via registered direct offering to single institutional investor at 0.90, closing at 30th April. Expect some news to come soon? still holding here. In 5 days or so, we shall see on the filling who bought it.
$Iterum Therapeutics (ITRM.US)$someone bought huge amount at here between 250k and another 100k?, we’re on six month after the FDA drug approved. Likely buyer - Amazon Clinic or Amgen.
$Iterum Therapeutics (ITRM.US)$let see if we get any news on buyout on this month or next month. as of now, they have yet to release the presentation on their website, possible of something holding it?
$Iterum Therapeutics (ITRM.US)$stuck at 1.3 and cannot go lower anymore. Pending buyover on the FDA approved drug. As per market talks, somewhere in March or April 2025. They have sufficient cash until Jun25. Recent appointment of director not having equity grant, possible sign they’re discussing/looking for buyer etc.
Report
No comment yet
Sign in to post a comment
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Iterum Therapeutics Stock Forum
Groundbreaking Research Reveals Age-Specific Patterns in Antibiotic Resistance for UTI Patients
No comment yet